XML 66 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
Financial Instruments
6 Months Ended
Jun. 30, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Financial Instruments
Financial Instruments

The Company’s financial instruments include cash and marketable securities. Due to the short-term nature of these instruments, their book value approximates their fair value. The Company’s financial instruments also include long-term debt, interest rate and cross-currency swaps, commodity derivative contracts and foreign currency derivatives. All derivative contracts are placed with counterparties that have an S&P, or equivalent, investment grade credit rating at the time of the contracts’ placement. At June 30, 2014 and December 31, 2013, the Company had no derivative contracts that contained credit risk related contingent features.

The Company selectively uses cross-currency swaps to hedge the foreign currency exposure associated with its net investment in certain foreign operations (net investment hedges). At June 30, 2014 and December 31, 2013, the following cross-currency swaps were outstanding:

(in millions)
 
 Cross-currency swaps
As of June 30, 2014
 
Notional in
USD
 
Notional in
local currency
 
Duration
Floating $ to floating €
 
$
75.0

 
58.5

 
Oct - 19
Floating $ to floating ¥
 
$
125.0

 
¥
14,651.3

 
Nov - 16


(in millions)
 
 Cross-currency swaps
As of December 31, 2013
 
Notional in
USD
 
Notional in
local currency
 
Duration
Floating $ to floating €
 
$
75.0

 
58.5

 
Oct - 19
Floating $ to floating ¥
 
$
150.0

 
¥
17,581.5

 
Nov - 16


The Company uses certain commodity derivative contracts to protect against commodity price changes related to forecasted raw material and supplies purchases. The Company primarily utilizes forward and option contracts, which are designated as cash flow hedges. The Company did not have any commodity derivative contracts outstanding at June 30, 2014 and December 31, 2013.

The Company uses foreign currency forward and option contracts to protect against exchange rate movements for forecasted cash flows, including capital expenditures, purchases, operating expenses or sales transactions designated in currencies other than the functional currency of the operating unit. Foreign currency derivative contracts require the Company, at a future date, to either buy or sell foreign currency in exchange for the operating units’ local currency.

At June 30, 2014 and December 31, 2013, the following foreign currency derivative contracts were outstanding:

Foreign currency derivatives (in millions)
Functional currency
 
Traded currency
 
Notional in traded currency
June 30, 2014
 
Notional in traded currency
December 31, 2013
 
Duration
Brazilian real
 
US dollar
 
9.9

 
19.3

 
Dec - 14
Chinese yuan
 
Japanese yen
 

 
215.0

 
Feb - 14
Chinese yuan
 
US dollar
 
6.5

 
12.3

 
Dec - 14
Euro
 
British pound
 
1.5

 
3.0

 
Dec - 14
Euro
 
Hungarian forint
 
3,175.5

 
6,430.5

 
Dec - 14
Euro
 
Japanese yen
 
2,779.0

 
5,830.7

 
Dec - 14
Euro
 
Korean won
 
109.9

 
663.1

 
Jul - 14
Euro
 
Polish zloty
 
45.6

 
96.0

 
Dec - 14
Euro
 
US dollar
 
15.3

 
29.4

 
May - 15
Hungarian forint
 
Euro
 
3.3

 
6.6

 
Dec - 14
Japanese yen
 
Chinese yuan
 
43.0

 
84.0

 
Dec - 14
Japanese yen
 
Korean won
 
3,446.7

 
5,715.5

 
Dec - 14
Japanese yen
 
US dollar
 
1.8

 
4.2

 
Dec - 14
Korean won
 
Euro
 
13.7

 
23.6

 
Dec - 15
Korean won
 
Japanese yen
 
216.9

 
380.5

 
Dec - 14
Korean won

US dollar
 
7.4

 

 
Dec - 14
Mexican peso
 
US dollar
 
7.6

 

 
Dec - 14
Swedish krona
 
Euro
 
17.6

 
33.7

 
Dec - 14
US dollar
 
Japanese yen
 
3,069.8

 
3,209.3

 
Sept - 14


At June 30, 2014 and December 31, 2013, the following amounts were recorded in the Condensed Consolidated Balance Sheets as being payable to or receivable from counterparties under ASC Topic 815:
 
 
Assets
 
Liabilities
(millions of dollars)
 
Location
 
June 30, 2014
 
December 31, 2013
 
Location
 
June 30, 2014
 
December 31, 2013
Foreign currency contracts
 
Prepayments and other current assets
 
$
3.5

 
$
3.4

 
Accounts payable and accrued expenses
 
$
2.8

 
$
7.4

 
 
Other non-current assets
 
$
0.2

 
$

 
Other non-current liabilities
 
$

 
$

Net investment hedge contracts
 
Other non-current assets
 
$

 
$

 
Other non-current liabilities
 
$
26.0

 
$
24.3


Effectiveness for cash flow and net investment hedges is assessed at the inception of the hedging relationship and quarterly, thereafter. To the extent that derivative instruments are deemed to be effective, gains and losses arising from these contracts are deferred into accumulated other comprehensive income (loss) ("AOCI") and reclassified into income as the underlying operating transactions are recognized. These realized gains or losses offset the hedged transaction and are recorded on the same line in the statement of operations. To the extent that derivative instruments are deemed to be ineffective, gains or losses are recognized into income.

The table below shows deferred gains (losses) reported in AOCI as well as the amount expected to be reclassified to income in one year or less. The amount expected to be reclassified to income in one year or less assumes no change in the current relationship of the hedged item at June 30, 2014 market rates.

(millions of dollars)
 
Deferred gain (loss) in AOCI at
 
Gain (loss) expected to be reclassified to income in one year or less
Contract Type
 
June 30, 2014
 
December 31, 2013
 
Foreign currency
 
$
0.4

 
$
(3.7
)
 
$
0.1

Net investment hedges
 
(28.1
)
 
(22.1
)
 

Total
 
$
(27.7
)
 
$
(25.8
)
 
$
0.1



Derivative instruments designated as hedging instruments as defined by ASC Topic 815 held during the period resulted in the following gains and losses recorded in income:

 
 
 
 
Gain (loss) reclassified
from AOCI to income
(effective portion)
 
 
 
Gain (loss)
recognized in income
(ineffective portion)
(millions of dollars)
 
 
 
Three Months Ended
 
 
 
Three Months Ended
Contract Type
 
Location
 
June 30, 2014
 
June 30, 2013
 
Location
 
June 30, 2014
 
June 30, 2013
Foreign currency
 
Sales
 
$
1.0

 
$
(0.3
)
 
SG&A expense
 
$
0.1

 
$
0.1

Foreign currency
 
Cost of goods sold
 
$
(1.0
)
 
$
(4.6
)
 
SG&A expense
 
$

 
$
(0.4
)
Foreign currency
 
SG&A expense
 
$
(0.1
)
 
$
(0.1
)
 
SG&A expense
 
$

 
$

Cross-currency swap
 
N/A
 
 
 
 
 
Interest expense
 
$

 
$
0.4



 
 
 
 
Gain (loss) reclassified
from AOCI to income
(effective portion)
 
 
 
Gain (loss)
recognized in income
(ineffective portion)
(millions of dollars)
 
 
 
Six Months Ended
 
 
 
Six Months Ended
Contract Type
 
Location
 
June 30, 2014
 
June 30, 2013
 
Location
 
June 30, 2014
 
June 30, 2013
Foreign currency
 
Sales
 
$
1.3

 
$
0.9

 
SG&A expense
 
$
0.1

 
$
0.2

Foreign currency
 
Cost of goods sold
 
$
(1.8
)
 
$
(6.0
)
 
SG&A expense
 
$
0.1

 
$
(0.7
)
Foreign currency
 
SG&A expense
 
$
(0.4
)
 
$
(0.1
)
 
SG&A expense
 
$

 
$

Cross-currency swap
 
N/A
 
 
 
 
 
Interest expense
 
$
0.7

 
$
(0.3
)

At June 30, 2014, derivative instruments that were not designated as hedging instruments as defined by ASC Topic 815 were immaterial.